FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team

August 9, 2024 7:30 AM

TORONTO, ON / ACCESSWIRE / August 9, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update on its investment in Celly Nutrition Corp. ("Celly Nu"), a privately held Canadian company launching an innovative beverage product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption.On August 9, 2024, Celly Nutrition which is backed by a world-class pharmaceutical research &...

Read more

Next Health Celebrates Eight Years of Pioneering Proactive Healthcare, Commits to Continued Innovation and Growth

August 9, 2024 7:15 AM

Next Health, the pioneer of data-driven proactive healthcare, proudly celebrated its eighth anniversary with events, promotions, and reinforced commitments for long-term continued growth. Founded on the vision of improving the healthspan and extending the lifespan of its customers, Next Health is the leader in personalized, data-driven health optimization & longevity that streamlines patient access to cutting-edge services and technology either...

Read more

Cantargia Reports Progress and Strong Biomarker Data from Phase I Clinical Trial with CAN10

August 9, 2024 4:20 AM

LUND, SWEDEN / ACCESSWIRE / August 9, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported progress in the ongoing phase I clinical trial of CAN10. The independent data monitoring committee has reviewed unblinded data from study participants in the ongoing single dose part of the trial and recommended continuation to the next phase, multiple dosing in participants with psoriasis, planned to start during...

Read more

Cheyanne Mallas, CEO and Founder of The Private Suite LA, Announces the Launch of North S.T.A.R. Technologies

August 8, 2024 7:30 PM

LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / In the dynamic world of cosmetic dermatology, Cheyanne Mallas The CEO and Founder of The Private Suite LA stands out as she has carved out a distinguished career specializing in bioregenerative aesthetics, facial optimization and structural rejuvenation. She is a serial entrepreneur, angel investor and Celebrity Injector. Now, she is poised to revolutionize the industry further with her latest...

Read more

Patients for Patient Safety US to Celebrate New Patient Safety Rules on World Patient Safety Day

August 8, 2024 7:00 PM

WASHINGTON, DC / ACCESSWIRE / August 8, 2024 / As World Patient Safety Day 2024 approaches on September 17th, Patients for Patient Safety US (PFPS US) commends the U.S. Centers for Medicare and Medicaid Services (CMS) for adding a game-changing new Patient Safety Structural Measure (PSSM) to the payment and policy rules for hospitals providing services under Medicare, Medicaid and the Children's Health Insurance Program.Starting on October 1,...

Read more

StrideCare Center of Excellence Opens in Denison, Offering Comprehensive Vascular, Podiatry and Wound Care

August 8, 2024 6:55 PM

StrideCare, the largest multi-specialty medical network in Texas, announces the opening of its new StrideCare Center of Excellence in Denison, Texas. This state-of-the-art facility combines vascular, podiatry and wound care services, offering comprehensive lower extremity care to patients in Grayson County and Southern Oklahoma.Located at 4616 U.S. 75, Suite 170, Denison, Texas 75020, the clinic is easily accessible from US Highway 75 and Pool...

Read more

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

August 8, 2024 5:20 PM

DENVER, CO / ACCESSWIRE / August 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq: AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, Chief Executive Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Sidoti Micro-Cap Virtual Conference, taking place virtually on Wednesday, August 14, 2024, and Thursday, August 15,...

Read more

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

August 8, 2024 4:10 PM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for its third fiscal quarter ended June 30, 2024. The Company's Form 10-Q can be viewed at https://investors.adnas.com/sec-filings/.Third Quarter Operational Highlights and Corporate Updates:LineaRx (Therapeutic DNA Production Services)GMP roadmap execution:On schedule for the FY24...

Read more

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

August 8, 2024 4:10 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced financial results for its first fiscal quarter ended June 30, 2024."This year marks the...

Read more

BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen

August 8, 2024 4:05 PM

LAKE FOREST, CA / ACCESSWIRE / August 8, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported its financial results for the second quarter ended June 30, 2024."We experienced another strong quarter in consumable revenue, recording our second-highest mark ever and achieving over 600 recurring subscriptions," commented John Beaver, President and Chief Executive Officer of BIOLASE. "This success translates to over...

Read more

Avinger Reports Second Quarter 2024 Results

August 8, 2024 4:01 PM

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the second quarter ended June 30, 2024.Second Quarter and Recent HighlightsReported second quarter 2024 revenue of $1.8 million, with a sequentially increased gross margin of 20%Streamlined operating costs...

Read more

NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

August 8, 2024 2:15 PM

NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based DNA vaccine designed to target patient-specific tumor neoantigens. This important and promising collaboration aims to enhance the production of personalized cancer treatments by leveraging the biotechnology strengths of both companies.Advancing Personalized Cancer TreatmentNEC Bio Therapeutics, a...

Read more

Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

August 8, 2024 1:00 PM

CHICAGO, IL / ACCESSWIRE / August 8, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has completed the registration process to commence sales in Germany...

Read more

KERATO Celebrates 5-Year Anniversary with New Miami Location and Over 1000 Successful Cases

August 8, 2024 12:00 PM

NEW YORK, NY and MIAMI, FL / ACCESSWIRE / August 8, 2024 / Imagine a world where changing your eye color is not just a dream but a safe and seamless reality. This vision has been materialized through the innovative efforts of KERATO, a pioneer in the field of cosmetic keratopigmentation. As KERATO celebrates its 5-year anniversary, it proudly announces the opening of a new location in Miami, further expanding its reach and bringing its...

Read more

Truss Health and KIMS Hospital Announce Strategic Partnership to Revolutionize Postoperative Care using AI-Powered Sensor Fusion Technology

August 8, 2024 11:03 AM

Truss Health, a leading innovator in healthcare technology, is excited to announce a strategic partnership with KIMS Hospital group , one of the largest corporate healthcare groups in India. This collaboration aims to significantly enhance postoperative care and infection control by integrating Truss Health's advanced AI-driven sensor fusion technology with KIMS Hospital's clinical expertise.From left to right: Dr. Abhinay Bollineni, CEO KIMS...

Read more

Electromedical Provides Update to Shareholders

August 8, 2024 11:00 AM

Electromedical (EMED), a Leader in Bioelectronic Medical Devices, Updates Shareholders on Recent Achievements and Strategic AdvancementsSCOTTSDALE, AZ / ACCESSWIRE / August 8, 2024 / Electromedical (OTC PINK:EMED), a leading innovator in bioelectronic medical devices, is pleased to provide an update to its shareholders, highlighting significant recent achievements and strategic advancements. EMED Logo Sales Growth: 17% increase in revenue in...

Read more

My Quest Story - Jamie Croft

August 8, 2024 10:45 AM

NORTHAMPTON, MA / ACCESSWIRE / August 8, 2024 / Quest Diagnostics National Logistics Day was June 28th. Join us in celebrating our logistics professionals who play a vital role in ensuring each specimen is treated like a life and delivered to our labs across the country. Thank you for your hard work and dedication to our purpose of working together to create a healthier world, one life at a time.---I had always wanted to do something in the...

Read more

Closing the HIV Diagnosis Gap in Germany with Gilead Sciences

August 8, 2024 10:15 AM

NORTHAMPTON, MA / ACCESSWIRE / August 8, 2024 / Gilead SciencesAs a nation where 90% of all people living with HIV know their diagnosis and are being treated, Germany has made great strides to advance its HIV care goals. Yet the country acknowledges it still has significant work to do to close the gaps in diagnosis that still exist, mainly in its rural and migrant communities.Early diagnosis is essential to help end the HIV epidemic, which is...

Read more

Superhuman 2 "Rebirth" Introducing Nikki

August 8, 2024 8:30 AM

Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), is partnering with Caroline Cory, an Award Winning Executive Producer known for her documentaries that air on Netflix and Prime Video. Caroline has millions of viewers and continues to produce films of interest, particularly in the world of frequencies.In 2020, an...

Read more

Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update

August 8, 2024 8:05 AM

SEATTLE, WA / ACCESSWIRE / August 8, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended March 31, 2024 and provided a business update."After the successful completion of our APVO436 dose expansion trial, where we saw a 91%...

Read more